Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PIRS Pieris Pharmaceuticals Inc

16,70

0,60 (3,73%)

05 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Pieris Pharmaceuticals Charts.

News Pieris Pharmaceuticals Inc

Form 425 - Prospectuses and communications, business combinations
Dienstag 3 Dezember 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 3 Dezember 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 18 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Donnerstag 7 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations
Donnerstag 7 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Mittwoch 6 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Donnerstag 17 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Donnerstag 17 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 425 - Prospectuses and communications, business combinations
Dienstag 15 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Donnerstag 3 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Pieris Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen